How to Cite
Abstract
Currently there is an increase in the incidence of cancer during pregnancy due to the postponement of procreation at a later age. The incidence of cervical cancer is 7.5-4.5 per 100,000 pregnancies and treatment remains an urgent problem and implies a multidisciplinary approach. The article describes the results of successful complex treatment for IB stage cervical cancer against the background of developing pregnancy with the inclusion of neoadjuvant chemotherapy followed by cesarean section, optimal surgery and brachytherapy.
References
Урманчеева А.Ф. Рак шейки матки и беременность // Практическая онкология. -2002. - Т. 3. - № 3. - С. 183-193.
Чернышова А.Л., Коломиец Л.А. Возможности лечения HPV-ассоциированого предрака и рака шейки матки препаратом «Гроприноссин» // Русский медицинский журнал. - 2012. - Т. 20. - № 1. - С. 11-15.
Чернышова А.Л., Коломиец Л.А., Чуруксаева О.Н., Литвин А.А. Новые подходы к лечению предрака и рака шейки матки // Цитокины и воспаление. - 2009. - Т. 8. - № 1. - С.51-53.
Amant F., Halaska M.J., Fugamalli M. et al. Gynecologic Cancers in Pregnancy: guidelines of a second international consensus meeting // International Journal of Gynecological Cancer. - 2014. - Vol. 24 (3). - P 394-403.
Amant F., Van Calsteren K. et al. Gynecologic cancers in pregnancy: guidelines of an international consensus meeting // International Journal of Gynecological Cancer. - 2009. - Vol. 19. - P. 1-12.
Amant F., Van Calsteren K., Halaska M.J. et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study // Lancet Oncol. - 2012. - Vol. 13(3). - P. 256-264.
Bisseling K.C., Bekkers R.L., Rome R.M., Quinn M.A. Treatment of microinvasive adenocarcinoma of the uterine cervix: A retrospective study and review of the literature // Gynecol. Oncol. - 2007. - Vol. 107. - P. 424-430.
Briggs G., Freeman R.K., Yaffe S.J. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. 9 ed. Lippincott Williams & Wilkins; 2011.
Cardonick E. Treatment of maternal cancer and fetal development // Lancet Oncol. - 2012. - Vol. 13 (3). - P. 218-220.
Cardonick E., Iacobucci A. Use of chemotherapy during human pregnancy // Lancet Oncol. - 2004. - Vol. 5(5). - P 283-291.
Doll D.C., Ringenberg Q.S., Yarbro J.W. Antineoplastic agents and pregnancy // semin Oncol. - 1989. - Vol. 16 (5). - P. 337-346.
Fruscio R., Villa A., Chiari S. et al. Delivery delay with neoadjuvant chemotherapy for cervical cancer patients during pregnancy: a series of nine cases and literature review // Gynecol. Oncol. - 2012. - Vol. 126. - P 192-197.
Gedeon C., Koren G. Designing pregnancy centered medications: drugs which do not cross the human Placenta // Placenta. - 2006. - Vol. 27 (8). - P. 861-868.
Khusen D., Purwoto G., Rachimhadhi T. Pregnancy with Cervical Cancer. CDK-206. - 2013. - Vol. 7. - P 504-507.
Kyrgiou M., Tsoumpou I., Vrekoussis T. et al. The up-to-date evidence on colposcopy practice and treatment of cervical intraepithelial neoplasia: The Cochrane colposcopy & cervical cytopatology collaborative group (C5 group) approach // Cancer Treat. Rev. - 2006. - Vol. 32. - P. 516-523.
Larson W.J., Larson WJ. Essentials of human embryology. New York: Churchill Livingstone, 1998.
Loibl S., Han S.N., von Minckwitz G. et al. Treatment of breast cancer during pregnancy: an observational study // Lancet. Oncol. - 2012. - Vol. 13 (9). - P 887-896.
Moore D., Blessing J., McQuellon R. et al. (2004) Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study // J. Clin. Oncol. - 2004. - Vol. 22. - P 3113-3119.
Moore K.L., Persaud TVN, Torchia M.G. Body Cavities and Diaphragm. The developing human: clinically oriented embryology. - 9 ed. Philadelphia: Saunders, 2011.
Nygard M., Daltveit A.K., Thoresen S.O., Nygard J.F Effect of an antepartum Pap smear on the coverage of a cervical cancer screeninig programme: A population-based prospective study // BMC Health Serv Res. - 2007. - Vol. 7. - P 10.
Pasternak B., Svanstrom H., Hviid A. Ondansetron in pregnancy and risk of adverse fetal outcomes // N. Engl. J. Med. - 2013. - Vol. 368(9). - P 814-823.
Pentheroudakis G., Orecchia R., Hoekstra H.J., Pavidis N. Минимальные клинические рекомендации ESMO по диагностике, лечению и наблюдению онкологических заболеваний у беременных. - 2010. - C. 404-411.
Rennick G.J. Use of systemic glucocorticosteroids in pregnancy: be alert but not alarmed // Australas J. Dermatol. - 2006. - Vol. 47(1). - P. 34-36.
Scarpellini F., Sbracia M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial // Hum. Re-prod. - 2009. - Vol. 24 (11). - P. 2703-2708.
Scott L.L., Ramin S.M., Richey M. et al. III. Erythropoietin use in pregnancy: two cases and a review of the literature // Am. J. Perinatol. - 1995. - Vol. 12 (1). - P. 22-24.
Udink Ten Cate FE, ten Hove CH, Nix WM et al. Transient neonatal myelosuppression after fetal exposure to maternal chemotherapy. Case report and review of the literature // Neonatology. - 2009. - Vol. 95 (1). - P. 80-85.
Ustaalioglu B.B., Gumus M., Unal A., Cayir K. et al. Malignancies Diagnosed during pregnancy and treated with chemotherapy or other modalities (review of 27 cases): multicenter experiences // Int. J. Gynecol. Cancer. - 2010. - Vol. 20 (5). - P 698-703.
Van Calsteren K., Heyns L., De Smet F. et al. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes // J. Clin. Oncol. - 2010. - Vol. 28 (4). - P 683-689.
Van Calsteren K., Verbesselt R., Ottevanger N. et al. Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study //Acta Obstet. Gynecol. Scand. - 2010. - Vol. 89 (10). - P 1338-1345.
Van Calsteren K., Vergote I., Amant F. Cervical neoplasia during pregnancy. Diagnosis, management and prognosis // Best Pract. Res. Clin. Obstet. Gynecol. - 2005. - Vol. 19. - P 611-630.
Weisz B., Meirow D., Schiff E. et al. Impact and treatment of cancer during pregnancy // Expert. Rev. Anticancer. Ther. - 2004. - Vol. 4(5). - P 889-902.
Williams S.F., Schilsky R.L. Antineoplastic drugs administered during pregnancy // Semin. Oncol. - 2000. - Vol. 27 (6). - P 618-622.
Zagouri F., Sergentanis T., Chrysikos D., Bartsch R. Platinum derivatives during pregnancy in cervical cancer: a systematic review and meta-analysis // Obstet. Gynecol. - 2013. - Vol. 121. - P. 337-343.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.